ADENOSINE RECEPTOR ANTAGONIST
Nourianz is a prescription drug approved by the Food and Drug Administration (FDA) to treat adults with Parkinson’s experiencing “off” episodes. Nourianz is also referred to by its drug name, istradefylline.
Nourianz is used as adjunctive treatment to levodopa and carbidopa for Parkinson’s. Nourianz is a member of a class of drugs called adenosine receptor antagonists. Nourianz is believed to work by reducing the overactivity in the brain region that causes Parkinson’s symptoms, but its exact mechanism is unknown.
How do I take it?
Prescribing information states that Nourianz is taken orally once per day.
Nourianz comes in tablet form.
The FDA-approved label for Nourianz lists common side effects including uncontrolled movements, dizziness, constipation, nausea, and trouble sleeping.
Rare but serious side effects listed for Nourianz include hallucinations, other psychotic behavior, and compulsive behavior or poor impulse control.
For more details about this treatment, visit:
Nourianz — Kyowa Kirin
Nourianz – FDA Label
We never share your personal information with anyone.
Want to stay up to date on the latest news and articles about Parkinson's disease?